eli lilly sues four telehealth compounding glp-1 companies selling alternative versions of its weight loss drug Telehealth Companies Sued for Selling

As a result, the U.S

GLP-1 receptor agonists slow the rate at which food moves from the stomach into the small intestine, prolonging feelings of fullness and helping to reduce overall calorie intake

pylori Helicobacter pylori Bcl-2 B-cell lymphoma 2 Bax Bcl-2-associated X LPS lipopolysaccharide PI3K phosphatidylinositol 3-kinase UC ulcerative colitis CD Crohns disease DSS dextran sulfate sodium TNBS 2,4,6-trinitrobenzene sulfonic acid FD functional dyspepsia IBS irritable bowel syndrome IBS-D diarrhea-predominant IBS IBS-C constipation-predominant IBS CC cancer cachexia Glossary References 1

Rocio Salas-Whalen explains, obesity and weight gain are multifactorial, and GLP-1s can only tackle one piece of the puzzle